Ultra Clean Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ultra Clean Holdings, Inc. on July 27, 2017. The filing primarily addresses the announcement of financial results for the second fiscal quarter ended June 30, 2017, and significant changes in executive leadership.
Financial Metrics
The filing references a press release (Exhibit 99.1) containing the financial results for the second fiscal quarter ended June 30, 2017. However, the text of this 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these details.
Material Changes and Executive Leadership
- CEO Leave of Absence: Jim Scholhamer, the current Chief Executive Officer, will take a leave of absence starting July 31, 2017, to address a medical condition. The leave is expected to last approximately two months.
- Acting CEO Appointment: Sheri Brumm, the current Chief Financial Officer and Senior Vice President of Finance, has been named Acting Chief Executive Officer during Mr. Scholhamer's absence.
- Compensation Adjustment: In recognition of her expanded duties, Ms. Brumm's annual target bonus for the second half of fiscal 2017 will increase from 75% to 100% of her base salary.
- Equity Award: Ms. Brumm will receive an award of 10,000 restricted stock units, vesting in three equal installments on each anniversary of the grant date.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, or management commentary regarding future financial performance beyond the reference to the attached press release. The primary risk disclosed in this document relates to the temporary absence of the CEO and the reliance on the Acting CEO to manage operations.
Key Facts for Investor Verification
- Verify the specific financial results for the quarter ended June 30, 2017, by reviewing the attached Press Release (Exhibit 99.1), as this 8-K does not list the figures.
- Confirm the duration of Jim Scholhamer's medical leave and the timeline for his potential return.
- Review the terms of the 10,000 restricted stock units granted to Sheri Brumm under the Company's Stock Incentive Plan.
- Monitor subsequent filings for any updates on the CEO's health status or permanent leadership changes.